Skip to main content

Colon Cancer Lawsuit Filed Over Contaminated Valsartan Drug

Colon Cancer Lawsuit Filed Over Contaminated Valsartan Drug

Colon Cancer Lawsuit Filed Over Contaminated Valsartan Drug

Introduction

According to a recently filed product liability lawsuit, exposure to valsartan drugs containing impurities caused a Mississippi man colon cancer.

The lawsuit was filed by a plaintiff in the U.S. District Court for the Southern District of Mississippi against Aurobindo Pharma and Acetris, LLC. The plaintiff stated that he was prescribed valsartan for the treatment of high blood pressure in February 2017. He was diagnosed with colon cancer, and in February 2018, he discovered that the pills he consumed were recalled due to contamination reports. The lawsuit stated that the manufacturers purposely concealed that the drug contained carcinogens, such as N-nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA), until the FDA issued its recall in July 2018. These chemicals have been reported to cause liver cancer, colon cancer, stomach cancer, and other digestive tract cancers.

This case is one among the growing number of valsartan recall lawsuits filed in recent months by individuals who were affected by the drug contamination.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.